2022 annual financial data
RenovoRx, Inc. 2022 Operating margin
RenovoRx, Inc. 2022 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -9,950,000 USD and net income was -9,771,000 USD.
Operating cash flow was -8,811,000 USD.
Get free RenovoRx, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -9,950,000 USD
- Net income
- -9,771,000 USD
- Operating cash flow
- -8,811,000 USD